Table 2.
Clinical profile of patients with MPC combined with APL reported in the literature, 2000-2020.
| Author | Year | NO. | Age | Gender | Solid tumours | APLTreatment | Prognosis | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Part | Pathology | Staging | Treatment | |||||||
| Mi Rui Hua et al. (6) | 2020 | 2 | 58 | Female | Breast | Invasive ductal carcinoma | Stage II | Surgery + chemotherapy | Tretinoin 、As2O3、IA、HA、MA、DA | Stable follow-up visits |
| 52 | Female | Esophagus | Squamous cell carcinoma | Stage I | Surgery | Tretinoin、As2O3、IA、HA、ID-Ara-cx2 | Stable follow-up visits | |||
| ShaLiu, et al. (7) | 2019 | 1 | 56 | Male | Esophagus | Squamous cell carcinoma | Stage IIIB | Surgery + chemotherapy + radiotherapy | Tretinoin、As2O3 | Died |
| Wu Zhijun et al. (8) | 2009 | 1 | 54 | Female | Ovarian | Mucinous cystic adenocarcinoma | Stage III C | Surgery + chemotherapy | Tretinoin | Died |
| Li Weibin et al. (9) | 2002 | 1 | 55 | Male | Gastric | – | – | Surgery + chemotherapy | – | Died |